- Home
- ADVB vs DXST Comparison
ADVB vs DXST Comparison
Compare ADVB & DXST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADVB
- DXST
- Stock Information
- Founded
- ADVB 2014
- DXST 2011
- Country
- ADVB United States
- DXST China
- Employees
- ADVB N/A
- DXST N/A
- Industry
- ADVB Medical Specialities
- DXST
- Sector
- ADVB Health Care
- DXST
- Exchange
- ADVB Nasdaq
- DXST NYSE
- Market Cap
- ADVB 20.8M
- DXST 18.7M
- IPO Year
- ADVB 2025
- DXST 2025
- Fundamental
- Price
- ADVB $0.69
- DXST $1.16
- Analyst Decision
- ADVB
- DXST
- Analyst Count
- ADVB 0
- DXST 0
- Target Price
- ADVB N/A
- DXST N/A
- AVG Volume (30 Days)
- ADVB 57.0K
- DXST 25.8K
- Earning Date
- ADVB 08-03-2025
- DXST 01-01-0001
- Dividend Yield
- ADVB N/A
- DXST N/A
- EPS Growth
- ADVB N/A
- DXST 13.11
- EPS
- ADVB N/A
- DXST 0.14
- Revenue
- ADVB N/A
- DXST $11,542,292.00
- Revenue This Year
- ADVB N/A
- DXST N/A
- Revenue Next Year
- ADVB N/A
- DXST N/A
- P/E Ratio
- ADVB N/A
- DXST $8.27
- Revenue Growth
- ADVB N/A
- DXST 22.18
- 52 Week Low
- ADVB $0.69
- DXST $0.85
- 52 Week High
- ADVB $4.10
- DXST $5.74
- Technical
- Relative Strength Index (RSI)
- ADVB N/A
- DXST N/A
- Support Level
- ADVB N/A
- DXST N/A
- Resistance Level
- ADVB N/A
- DXST N/A
- Average True Range (ATR)
- ADVB 0.00
- DXST 0.00
- MACD
- ADVB 0.00
- DXST 0.00
- Stochastic Oscillator
- ADVB 0.00
- DXST 0.00
About ADVB Advanced Biomed Inc. Common Stock
Advanced Biomed Inc operates through its subsidiaries that are responsible for the main operation and the design and development of the company's primary technologies and products. It has been focusing on the integration of multiple interdisciplinary technologies and established its microfluidic technology platform. Utilizing the physical and molecular biological characteristics of tumor cells, the company has developed various advanced and original research through the joint application of semiconductor technology and biotechnology. devices, A+Pre, AC-1000, A+CellScan, and A+SCDrop, and three corresponding microfluidic biochips, A+Pre Chip and AC-1000 CTC Enrichment Chip and A+CellScan Chip, are designed to provide rapid and affordable assay products and services to cancer patients.
About DXST DECENT HOLDING INC
Decent Holding Inc through its subsidiary specializes in the provision of wastewater treatment by cleansing the industrial wastewater, ecological river restoration and river ecosystem management by enhancing the water quality, as well as microbial products used for pollutant removal and water quality enhancement. Its main services and products include (1) wastewater treatment, (2) river water quality management, and (3) microbial products for water quality enhancement and pollutant cleansing purposes. The company's focus is on research and development (R&D) to sharpen its innovation edge.